Default company panoramic image

Cascade Biotherapeutics, Inc

Translating advances in genomics into molecular diagnostics and therapies to deliver personalized medicine options to empower consumers.

  • Stage Product In Development
  • Industry Healthcare Services
  • Location Bethesda, MD, USA
  • Currency USD
  • Founded August 2012
  • Employees 5
  • Website

Company Summary

CBI is developing a portfolio of molecular diagnostic assays with the capacity to supply healthcare systems and consumers with the diagnostic intelligence necessary to improve personal and public health; Identify biomarkers that are predictive of an individual’s response to infectious disease, healthcare acquired infections, chronic illness and cancer. Identify targets for drug development, therapeutic monitoring and personalized medicine.


  • Default avatar
    Joseph Curtis
    CEO President

    Dr. Curtis is an experienced lifescience executive with a comprehensive background in assisting the Department of Defense healthcare organizations and global health nonprofits supporting public health preparedness to develop enterprise and business-level investment strategies needed to manage the risks associated with the development, testing and introduction of advanced medical technology into domestic and international markets.

  • Default avatar
    Michael Brown
    Chief Financial Officer

    Mr. Brown has 25 years of experience in advising organizations on account, taxation and corporate finance issues. Michael has supported a variety of industries including engineering firms developing laboratories, and facilities for medical centers. His practice includes advising municipal and state government agencies and supporting corporate clients with services to support mergers and acquisitions.

  • Default avatar
    Theophilus R. Nix Jr
    Corporate Council

    Theophilus R. Nix, Jr., Esq is currently corporate counsel for DuPont Corporation, USA where he reviews and drafts contracts for the company's $18 billion dollar sourcing department. Mr. Nix brings a breadth and depth of experience rarely seen and is a major part of our team. He will provide CBI with esceptional guldance and leadership as we move forward to supply consumers in domestic and international markets.

  • Default avatar
    Harold Aubrey
    Chief Analytics Officer

    Dr. Harold, Aubrey is a fellow at the National Center for Bioethics in Research and Healthcare with over 25 years of decision science, operations research, and translational research expertice. Harold designed statistical analysis supporting human clinical trials funded to evaluate the efficacy of anti-retroviral drugs used to treat populations infected with HIV/AIDS. He has also mentored doctoral level decision scientists practicing at the CDC


  • Default avatar
    Theophilus R. Nix, Jr